Mono Propylene Glycol (E1520) CAS: 57-55-6
Related Insights
China Text Helium Block and NMR Spectroscopy: What the Supply Crisis Means for Pharmaceutical Quality Control
Helium supply constraints are creating new challenges for pharmaceutical laboratories that rely on NMR spectroscopy for quality control. Procurement teams should review helium inventories, supplier allocations and long term supply resilience before laboratory operations are affected.
Iran’s “Service Fees”: What Toll-Based Passage Would Cost the Chemical Industry Annually
Iran’s proposal to charge “service fees” for Hormuz passage could permanently reshape the economics of global chemical trade. If transit charges become permanent, Gulf-origin chemical supply chains may face $500 million to $1.5 billion in additional annual costs that buyers will ultimately absorb through higher contract pricing.
Green Ammonia: The 60-Day MoU Clock and What It Means for Gulf Green Project Timelines
The 60-day diplomatic window following the June 2026 MoU is becoming a key milestone for green ammonia investments. Developers and industrial buyers are closely monitoring project timelines, supply security, and future procurement opportunities.
Stranded Vessel Update: The 485 Ships That Remain and How the Exit Queue Works
Although Gulf shipping has improved significantly since the peak of the Hormuz crisis, hundreds of vessels remain awaiting transit. Understanding the commercial priority system governing departures is essential for chemical buyers tracking delayed cargoes and planning H2 2026 deliveries.
Glycerin Pharmaceutical Grade: H1 Closing Review of EUDR and Supply Chain Challenges
Pharmaceutical-grade glycerin enters H2 2026 at the intersection of supply chain recovery and evolving sustainability regulations. Pharmaceutical buyers must balance USP/EP quality requirements with EUDR compliance while diversifying sourcing strategies.
Pharmaceutical Chemical Procurement Intelligence: June 24, 2026 Situation Report
Pharmaceutical procurement teams face an unusually complex H2 2026 environment shaped by GLP-1 manufacturing demand, excipient compliance changes, freight cost shifts, regulatory deadlines, and elevated drug shortage risk across critical therapeutic categories.
Don't miss out on our updates! Subscribe to our newsletter now
We're committed to your privacy. Tradeasia uses the information you provide to us to contact you about our relevant content, products, and services. For more information, check out our privacy policy.